NOVIELLE VOICE GEL PLUS 25301

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2010-04-05 for NOVIELLE VOICE GEL PLUS 25301 manufactured by Coapt Systems, Inc..

Event Text Entries

[16922064] It has been reported that the physician injected two syringes of novielle gel plus around the nasolabial folds and marionette lines on (b) (6) 2009. The pt developed painful lumps in the area of injection. The physician prescribed medication.
Patient Sequence No: 1, Text Type: D, B5


[17056416] The device was not returned to the mfr; therefore, an investigation to determine root cause could not be conducted. Novielle gel plus is designed for vocal fold augmentation. If add'l info becomes available, it will be submitted in a supplemental report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3003644133-2010-00002
MDR Report Key1652501
Report Source05
Date Received2010-04-05
Date of Report2010-02-22
Date of Event2009-03-19
Date Mfgr Received2010-02-22
Device Manufacturer Date2009-01-01
Date Added to Maude2010-04-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactGAIL STEWART, DIR.
Manufacturer Street1820 EMBARCADERO RD.
Manufacturer CityPALO ALTO CA 94303
Manufacturer CountryUS
Manufacturer Postal94303
Manufacturer Phone6504617600
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNOVIELLE VOICE GEL PLUS
Generic NameEAR, NOSE & THROAT SYNTHETIC POLYMER
Product CodeMIX
Date Received2010-04-05
Model Number25301
Catalog Number25301
Lot Number02402
Device Expiration Date2009-12-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCOAPT SYSTEMS, INC.
Manufacturer AddressPALO ALTO CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2010-04-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.